卒中相关性肺炎诊治中国专家共识(2019更新版)

2019-11-24 中国卒中学会 中国卒中杂志.2019,14(12):65-76.

为提高对SAP的认识,由我国神经内科、呼吸科、感染科及重症医学科等多学科专家于2009年成立专家组,共同讨论制定并发表《卒中相关性肺炎诊治中国专家共识》2010版,以规范国内SAP的临床诊疗。近年来,SAP相关研究领域积累了更多的临床证据,尤其是中国人群的证据亦在增加,我们对SAP的认识进一步加深。有鉴于此,神经内科、急诊科、呼吸科、感染科及重症医学科等多学科专家对原共识进行更新和修订,以适应SA

中文标题:

卒中相关性肺炎诊治中国专家共识(2019更新版)

发布机构:

中国卒中学会

发布日期:

2019-11-24

简要介绍:

为提高对SAP的认识,由我国神经内科、呼吸科、感染科及重症医学科等多学科专家于2009年成立专家组,共同讨论制定并发表《卒中相关性肺炎诊治中国专家共识》2010版,以规范国内SAP的临床诊疗。近年来,SAP相关研究领域积累了更多的临床证据,尤其是中国人群的证据亦在增加,我们对SAP的认识进一步加深。有鉴于此,神经内科、急诊科、呼吸科、感染科及重症医学科等多学科专家对原共识进行更新和修订,以适应SAP临床防治工作的需要。本版共识在2010版的基础上,经过多次工作会议,确定了整体框架和主要更新内容;结合国内外最新的研究进展和相关指南共识,并尽可能地采用我国SAP防治的实践经验和研究数据,经广泛征求意见和反复讨论修订而成,以期为临床SAP的防治工作提供参考。

 

拓展指南:卒中相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=卒中相关性肺炎诊治中国专家共识(2019更新版))] GetToolGuiderByIdResponse(projectId=1, id=a105a1c00183a059, title=卒中相关性肺炎诊治中国专家共识(2019更新版), enTitle=, guiderFrom=中国卒中杂志.2019,14(12):65-76., authorId=null, author=, summary=为提高对SAP的认识,由我国神经内科、呼吸科、感染科及重症医学科等多学科专家于2009年成立专家组,共同讨论制定并发表《卒中相关性肺炎诊治中国专家共识》2010版,以规范国内SAP的临床诊疗。近年来,SAP相关研究领域积累了更多的临床证据,尤其是中国人群的证据亦在增加,我们对SAP的认识进一步加深。有鉴于此,神经内科、急诊科、呼吸科、感染科及重症医学科等多学科专家对原共识进行更新和修订,以适应SA, cover=, journalId=null, articlesId=null, associationId=1192, associationName=中国卒中学会, associationIntro=中国卒中学会, copyright=0, guiderPublishedTime=Sun Nov 24 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>为提高对SAP的认识,由我国神经内科、呼吸科、感染科及重症医学科等多学科专家于2009年成立专家组,共同讨论制定并发表《卒中相关性肺炎诊治中国专家共识》2010版,以规范国内SAP的临床诊疗。近年来,SAP相关研究领域积累了更多的临床证据,尤其是中国人群的证据亦在增加,我们对SAP的认识进一步加深。有鉴于此,神经内科、急诊科、呼吸科、感染科及重症医学科等多学科专家对原共识进行更新和修订,以适应SAP临床防治工作的需要。本版共识在2010版的基础上,经过多次工作会议,确定了整体框架和主要更新内容;结合国内外最新的研究进展和相关指南共识,并尽可能地采用我国SAP防治的实践经验和研究数据,经广泛征求意见和反复讨论修订而成,以期为临床SAP的防治工作提供参考。</P> <P> </P>拓展指南:<strong>与<font color=red>卒中</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=9f8ae1c0018252e0" title="2019 AHA/ASA指南:急性缺血性卒中的早期管理(更新版)" target=_blank>2019 AHA/ASA指南:急性缺血性卒中的早期管理(更新版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=121e51c00181a895" title="急性缺血性脑卒中治疗药物临床试验技术指导原则" target=_blank>急性缺血性脑卒中治疗药物临床试验技术指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=bbd591c00181106e" title="中国脑血管病临床管理指南(节选版)——卒中康复管理" target=_blank>中国脑血管病临床管理指南(节选版)——卒中康复管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a94431c001802253" title="脑卒中水中运动治疗中国循证临床实践指南(2019版)" target=_blank>脑卒中水中运动治疗中国循证临床实践指南(2019版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=448cb1c001e9967b" title="中国脑血管病临床管理指南(节选版)——卒中组织化管理" target=_blank>中国脑血管病临床管理指南(节选版)——卒中组织化管理</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%8D%92%E4%B8%AD" target=_blank>有关卒中更多指南</a></ul>, tagList=[TagDto(tagId=28982, tagName=卒中相关性肺炎)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7106, appHits=911, showAppHits=13, pcHits=4082, showPcHits=3171, likes=83, shares=66, comments=9, approvalStatus=1, publishedTime=Thu Nov 28 22:16:52 CST 2019, publishedTimeString=2019-11-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 28 22:16:52 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 10:47:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=卒中相关性肺炎诊治中国专家共识(2019更新版))])
卒中相关性肺炎诊治中国专家共识(2019更新版)
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2121907, encodeId=6cc1212190e2a, content=卒中相关性肺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c024900444, createdName=呼噜呼噜, createdTime=Sun Mar 26 14:53:30 CST 2023, time=2023-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=969023, encodeId=e17c9690230f, content=想學習這文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=865b1314031, createdName=296146, createdTime=Thu May 27 21:56:31 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967812, encodeId=c15396e8126b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db05156467, createdName=146a90ecm93暂无昵称, createdTime=Sat May 22 19:52:33 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953020, encodeId=d9029530200a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921178, encodeId=9c8b9211e88f, content=值得学习和收藏,感谢知识分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/ca6cd5ba60124d63a9fd53c4f1fdf2ee/6c58ba1a86e1473bad79e40d422e2bfd.jpg, createdBy=e8605457150, createdName=ms1000000812157918, createdTime=Fri Jan 29 19:15:52 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2023-03-26 呼噜呼噜 来自北京

    卒中相关性肺炎

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2121907, encodeId=6cc1212190e2a, content=卒中相关性肺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c024900444, createdName=呼噜呼噜, createdTime=Sun Mar 26 14:53:30 CST 2023, time=2023-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=969023, encodeId=e17c9690230f, content=想學習這文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=865b1314031, createdName=296146, createdTime=Thu May 27 21:56:31 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967812, encodeId=c15396e8126b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db05156467, createdName=146a90ecm93暂无昵称, createdTime=Sat May 22 19:52:33 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953020, encodeId=d9029530200a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921178, encodeId=9c8b9211e88f, content=值得学习和收藏,感谢知识分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/ca6cd5ba60124d63a9fd53c4f1fdf2ee/6c58ba1a86e1473bad79e40d422e2bfd.jpg, createdBy=e8605457150, createdName=ms1000000812157918, createdTime=Fri Jan 29 19:15:52 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-05-27 296146

    想學習這文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2121907, encodeId=6cc1212190e2a, content=卒中相关性肺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c024900444, createdName=呼噜呼噜, createdTime=Sun Mar 26 14:53:30 CST 2023, time=2023-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=969023, encodeId=e17c9690230f, content=想學習這文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=865b1314031, createdName=296146, createdTime=Thu May 27 21:56:31 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967812, encodeId=c15396e8126b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db05156467, createdName=146a90ecm93暂无昵称, createdTime=Sat May 22 19:52:33 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953020, encodeId=d9029530200a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921178, encodeId=9c8b9211e88f, content=值得学习和收藏,感谢知识分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/ca6cd5ba60124d63a9fd53c4f1fdf2ee/6c58ba1a86e1473bad79e40d422e2bfd.jpg, createdBy=e8605457150, createdName=ms1000000812157918, createdTime=Fri Jan 29 19:15:52 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-05-22 146a90ecm93暂无昵称

    真好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2121907, encodeId=6cc1212190e2a, content=卒中相关性肺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c024900444, createdName=呼噜呼噜, createdTime=Sun Mar 26 14:53:30 CST 2023, time=2023-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=969023, encodeId=e17c9690230f, content=想學習這文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=865b1314031, createdName=296146, createdTime=Thu May 27 21:56:31 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967812, encodeId=c15396e8126b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db05156467, createdName=146a90ecm93暂无昵称, createdTime=Sat May 22 19:52:33 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953020, encodeId=d9029530200a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921178, encodeId=9c8b9211e88f, content=值得学习和收藏,感谢知识分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/ca6cd5ba60124d63a9fd53c4f1fdf2ee/6c58ba1a86e1473bad79e40d422e2bfd.jpg, createdBy=e8605457150, createdName=ms1000000812157918, createdTime=Fri Jan 29 19:15:52 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-04-01 baijerrywu

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2121907, encodeId=6cc1212190e2a, content=卒中相关性肺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c024900444, createdName=呼噜呼噜, createdTime=Sun Mar 26 14:53:30 CST 2023, time=2023-03-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=969023, encodeId=e17c9690230f, content=想學習這文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=865b1314031, createdName=296146, createdTime=Thu May 27 21:56:31 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967812, encodeId=c15396e8126b, content=真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1db05156467, createdName=146a90ecm93暂无昵称, createdTime=Sat May 22 19:52:33 CST 2021, time=2021-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953020, encodeId=d9029530200a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85531588690, createdName=baijerrywu, createdTime=Thu Apr 01 10:42:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921178, encodeId=9c8b9211e88f, content=值得学习和收藏,感谢知识分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/ca6cd5ba60124d63a9fd53c4f1fdf2ee/6c58ba1a86e1473bad79e40d422e2bfd.jpg, createdBy=e8605457150, createdName=ms1000000812157918, createdTime=Fri Jan 29 19:15:52 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 ms1000000812157918

    值得学习和收藏,感谢知识分享。

    0